Management of Aortic Stenosis in Patients With End-Stage Renal Disease on Hemodialysis.

ABSTRACT:

Background

Patients with end-stage renal disease on hemodialysis (ESRD-HD) and aortic stenosis have poor prognosis. The role of transcatheter aortic valve replacement (TAVR) in this high-risk population is debated.

Methods

We compared the outcomes among ESRD-HD Medicare beneficiaries who were managed with TAVR, surgical AVR (SAVR), or conservative management for aortic stenosis between 2015 and 2017, using overlap propensity score weighting analysis to control for differences in treatment assignment. The primary outcome was all-cause mortality and was compared between treatment groups as well as to age-sex matched mortality for ESRD-HD in the US population. Secondary outcomes included trend of heart failure hospitalizations.

Results

A total of 8107 ESRD-HD patients wi

SUBMITTER: Mentias A 

PROVIDER: S-EPMC7422925 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature